<p>Russia has applied to the World Health Organization for accelerated registration and pre-qualification of its Sputnik V coronavirus vaccine, the country's sovereign wealth fund said Tuesday.</p>.<p>Russia announced in August that it had registered the world's first coronavirus vaccine, named after the Soviet-era satellite.</p>.<p>On Tuesday, the Russian Direct Investment Fund, which finances the vaccine, said that accelerated registration would make Sputnik V "available globally in a shorter time frame than usual procedures."</p>.<p>"The Russian Federation has become one of the first countries to apply to WHO for pre-qualification of its vaccine against the novel coronavirus infection," RDIF said in a statement.</p>.<p>When contacted by AFP, the WHO said such requests were "confidential".</p>.<p><a href="https://www.deccanherald.com/science-and-environment/coronavirus-vaccine-live-updates-covaxin-clinical-trials-human-trials-coronavirus-vaccine%20tracker-india-russia-us-china-oxford-moderna-bharat-biotech-866148.html" target="_blank"><strong>Coronavirus vaccine news live updates on DH</strong></a></p>.<p>According to the Russian statement, "successful pre-qualification will enable Sputnik V to be included in the list of medicines used by international procurement agencies and countries to guide bulk purchasing of medicines."</p>.<p>Some Western scientists have expressed concern over the Russian vaccine, warning that moving too quickly could be dangerous.</p>.<p>The WHO told AFP: "If a product submitted for evaluation is deemed to conform to criteria for inscription on the list, the WHO will publish the results widely."</p>.<p>So far, the WHO said, it "has not yet pre-qualified a vaccine for Covid-19, nor published any emergency use listing."</p>.<p>That is "a risk-based procedure for assessing and listing unlicensed vaccines, therapeutics and in vitro diagnostics with the ultimate aim of expediting the availability of these products to people affected by a public health emergency," the WHO website says.</p>.<p>On Monday, British pharmaceuticals giant AstraZeneca said that trials of its coronavirus vaccine pioneered with Oxford University had shown "encouraging" responses among elderly, as well as younger participants.</p>.<p>It is considered one of the most promising and advanced in the world to combat the global pandemic, which has now claimed the lives of 1.1 million people.</p>.<p>Earlier this month, President Vladimir Putin announced that Russia had registered its second coronavirus vaccine, EpiVacCorona.</p>.<p>Russia has the fourth-highest virus caseload in the world, with a total of 1,547,774 registered infections and 26,589 deaths.</p>.<p>On Tuesday, Russian health authorities reported a record 320 deaths from the coronavirus over the past 24 hours as officials tightened anti-virus restrictions including enforcing mask-wearing in public spaces.</p>
<p>Russia has applied to the World Health Organization for accelerated registration and pre-qualification of its Sputnik V coronavirus vaccine, the country's sovereign wealth fund said Tuesday.</p>.<p>Russia announced in August that it had registered the world's first coronavirus vaccine, named after the Soviet-era satellite.</p>.<p>On Tuesday, the Russian Direct Investment Fund, which finances the vaccine, said that accelerated registration would make Sputnik V "available globally in a shorter time frame than usual procedures."</p>.<p>"The Russian Federation has become one of the first countries to apply to WHO for pre-qualification of its vaccine against the novel coronavirus infection," RDIF said in a statement.</p>.<p>When contacted by AFP, the WHO said such requests were "confidential".</p>.<p><a href="https://www.deccanherald.com/science-and-environment/coronavirus-vaccine-live-updates-covaxin-clinical-trials-human-trials-coronavirus-vaccine%20tracker-india-russia-us-china-oxford-moderna-bharat-biotech-866148.html" target="_blank"><strong>Coronavirus vaccine news live updates on DH</strong></a></p>.<p>According to the Russian statement, "successful pre-qualification will enable Sputnik V to be included in the list of medicines used by international procurement agencies and countries to guide bulk purchasing of medicines."</p>.<p>Some Western scientists have expressed concern over the Russian vaccine, warning that moving too quickly could be dangerous.</p>.<p>The WHO told AFP: "If a product submitted for evaluation is deemed to conform to criteria for inscription on the list, the WHO will publish the results widely."</p>.<p>So far, the WHO said, it "has not yet pre-qualified a vaccine for Covid-19, nor published any emergency use listing."</p>.<p>That is "a risk-based procedure for assessing and listing unlicensed vaccines, therapeutics and in vitro diagnostics with the ultimate aim of expediting the availability of these products to people affected by a public health emergency," the WHO website says.</p>.<p>On Monday, British pharmaceuticals giant AstraZeneca said that trials of its coronavirus vaccine pioneered with Oxford University had shown "encouraging" responses among elderly, as well as younger participants.</p>.<p>It is considered one of the most promising and advanced in the world to combat the global pandemic, which has now claimed the lives of 1.1 million people.</p>.<p>Earlier this month, President Vladimir Putin announced that Russia had registered its second coronavirus vaccine, EpiVacCorona.</p>.<p>Russia has the fourth-highest virus caseload in the world, with a total of 1,547,774 registered infections and 26,589 deaths.</p>.<p>On Tuesday, Russian health authorities reported a record 320 deaths from the coronavirus over the past 24 hours as officials tightened anti-virus restrictions including enforcing mask-wearing in public spaces.</p>